Gemphire Therapeutics Garners $5,150,500 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d2799c95-056c-4a3e-9025-17b076dd8ba6 - Date
4/27/2016 - Company Name
Gemphire Therapeutics - Mailing Address
43334 Seven Mile Road Northville, MI 48167 USA - Company Description
Our mission is to develop novel drugs, such as gemcabene, to treat the large, growing unmet need of dyslipidemia patients who are unable to reach optimal LDL cholesterol or triglyceride levels with statin or other therapies. - Website
http://www.gemphire.com - Transaction Type
Debt - Transaction Amount
$5,150,500 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 59 investors participated in the offering as amended. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
